Researchers from institutions such as Kyoto University in Japan published a paper in the new issue of the American “Science Advances” magazine saying that they have developed a low molecular weight compound that can fix RNA errors after oral administration, thus providing new ideas for treating rare genetic diseases caused by genetic mutations such as Fabry disease.

Researchers from institutions such as Kyoto University in Japan published a paper in the new issue of the American “Science Advances” magazine saying that they have developed a low molecular weight compound that can fix RNA errors after oral administration, thus providing new ideas for treating rare genetic diseases caused by genetic mutations such as Fabry disease.